ESSA Pharma Inc. (EPIX) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. (NASDAQ:EPIX) for potential violations of federal securities laws. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 05, 2024 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities law violations after halting a Phase 2 trial for a prostate cancer treatment.
The investigation by Levi & Korsinsky into potential securities law violations is significant, as it follows the company's decision to end a Phase 2 trial. This could negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100